Literature DB >> 9630241

Fate of Schwann cells in CMT1A and HNPP: evidence for apoptosis.

S Erdem1, J R Mendell, Z Sahenk.   

Abstract

The fate of Schwann cells in Charcot-Marie-Tooth (CMT) neuropathies was addressed in this study of nerve biopsies from patients with proven PMP22 duplications and deletions. In frozen sections, apoptotic nuclei were detected using the TUNEL method. In adjacent sections, anti-neurofilament 68kD antibody was used as an axonal marker, while the antibodies to NKH-1 and low-affinity nerve growth factor receptor P75NTR were used as Schwann cell markers. In addition, plastic sections were used to determine the densities of myelinated fibers and Schwann cell nuclei. In all biopsies from CMT1A, TUNEL-positive nuclei appeared in clusters. In adjacent sections, areas of TUNEL-positive nuclei matched with areas devoid of neurofilaments and NKH-1-positive Schwann cell silhouettes, suggesting that the apoptotic nuclei belonged to nonmyelinating Schwann cells. In addition, quantitative studies on plastic-embedded sections showed a significantly reduced number of total Schwann cells compared with controls, strongly favoring a loss of Schwann cell by apoptosis. In HNPP, the number of total Schwann cells was increased and a significant Schwann cell apoptosis was observed in only 2 patients. Examination of plastic sections and teased nerve preparations from these cases suggested that the Schwann cell apoptosis might be related to the regenerative state of the nerve resulting from the process of sprout pruning. No strict correlation between p75NTR expression and apoptosis was found. These studies indicate that factors regulating Schwann cell number in early postnatal development continue to be important for Schwann cell survival throughout life.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9630241     DOI: 10.1097/00005072-199806000-00009

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  6 in total

1.  Apoptosis is required during early stages of tail regeneration in Xenopus laevis.

Authors:  Ai-Sun Tseng; Dany S Adams; Dayong Qiu; Punita Koustubhan; Michael Levin
Journal:  Dev Biol       Date:  2006-11-06       Impact factor: 3.582

2.  Disruption of Endosomal Sorting in Schwann Cells Leads to Defective Myelination and Endosomal Abnormalities Observed in Charcot-Marie-Tooth Disease.

Authors:  John W McLean; Julie A Wilson; Tina Tian; Jennifer A Watson; Mary VanHart; Andrew J Bean; Steven S Scherer; David K Crossman; Eroboghene Ubogu; Scott M Wilson
Journal:  J Neurosci       Date:  2022-05-19       Impact factor: 6.709

Review 3.  The PMP22 gene and its related diseases.

Authors:  Jun Li; Brett Parker; Colin Martyn; Chandramohan Natarajan; Jiasong Guo
Journal:  Mol Neurobiol       Date:  2012-12-07       Impact factor: 5.590

4.  Rer1 and calnexin regulate endoplasmic reticulum retention of a peripheral myelin protein 22 mutant that causes type 1A Charcot-Marie-Tooth disease.

Authors:  Taichi Hara; Yukiko Hashimoto; Tomoko Akuzawa; Rika Hirai; Hisae Kobayashi; Ken Sato
Journal:  Sci Rep       Date:  2014-11-11       Impact factor: 4.379

5.  Clinical and Molecular Characterization of PMP22 point mutations in Taiwanese patients with Inherited Neuropathy.

Authors:  Yi-Chu Liao; Pei-Chien Tsai; Thy-Sheng Lin; Cheng-Tsung Hsiao; Nai-Chen Chao; Kon-Ping Lin; Yi-Chung Lee
Journal:  Sci Rep       Date:  2017-11-10       Impact factor: 4.379

6.  AAV1.NT-3 gene therapy for charcot-marie-tooth neuropathy.

Authors:  Zarife Sahenk; Gloria Galloway; Kelly Reed Clark; Vinod Malik; Louise R Rodino-Klapac; Brian K Kaspar; Lei Chen; Cilwyn Braganza; Chrystal Montgomery; Jerry R Mendell
Journal:  Mol Ther       Date:  2013-10-28       Impact factor: 11.454

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.